The structural profiles are close, with West Pharmaceutical Services carrying a narrow edge on profitability. GSK still leads on valuation and stability, which keeps the comparison from looking entirely one-sided. In the market, GSK carries the stronger setup — intact trend against West Pharmaceutical Services's broken trend. That leaves a split case: the structural lead stays with West Pharmaceutical Services, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels.
The comparison is mainly decided in profitability, with the rest of the profile carrying less weight.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
This level of similarity points to a meaningful structural match, though not a tight one.
Most of the shared profile comes through revenue growth trajectory and capital structure.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in profitability.
Left means cheaper relative valuation. Higher means stronger structure.
The structural gap is limited here, but current pricing still leans against West Pharmaceutical Services, Inc..
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The clearest distance comes from a stronger profitability profile.
Absolute pricing still looks more supportive for GSK, with a forward P/E that is 16.8 turns lower there.
The main read on profitability is clearer than the broader score gap.
Break down the GSK.L vs WST comparison across all dimensions with the full interactive tool.
Explore how GSK.L and WST each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.